Literature DB >> 25107446

Low-fat, high-carbohydrate parenteral nutrition (PN) may potentially reverse liver disease in long-term PN-dependent infants.

Marianne Skytte Jakobsen1, Marianne Hørby Jørgensen, Steffen Husby, Leis Andersen, Palle Bekker Jeppesen.   

Abstract

INTRODUCTION: Parenteral nutrition-associated cholestasis (PNAC) is a complication of long-term parenteral nutrition (PN). Removal of lipids may reverse PNAC but compromises the energy to ensure infant growth. The purpose of this study was to test whether a low-fat, high-carbohydrate PN regimen, which prevents and reverses PNAC in adults, could do the same in infants. This regimen could potentially avoid the problem of diminished energy input after removing nutritional lipids.
METHODS: Infants developing PNAC over a 2-year period were started on a low-fat PN regimen with calories primarily from carbohydrates. The fat-free PN, containing 314 kJ/ml, was provided 5-6 times a week and fat, including essential fatty acids and fat-soluble vitamins, 1-2 times a week. Enteral feeding was continued according to individual tolerance.
RESULTS: The study included 10 infants with short bowel syndrome (six with intestinal failure due to necrotizing enterocolitis, one with gastroschisis, one with complications due to unrecognized anal atresia and two with midgut volvulus). Median duration of PN with fat before initiating the low-fat regime was 69 days (25-75 % percentile: 41-75 days), and mean s-bilirubin was 139 µmol/l (range 87-323 µmol/l). Median duration with low-fat regimen was 69 days (25-75 % percentile: 18-123 days). Bilirubin reversed to normal (<50 µmol/l) in all infants. Seven children showed catch-up growth. No essential fatty acid deficiency, steatosis or deaths were observed.
CONCLUSIONS: A low-fat, high-carbohydrate PN regimen together with enteral feeding is well tolerated and may be used in reversing liver disease in PN-dependent infants without compromising growth.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25107446     DOI: 10.1007/s10620-014-3317-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  1. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR).

Authors:  Berthold Koletzko; Olivier Goulet; Joanne Hunt; Kathrin Krohn; Raanan Shamir
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-11       Impact factor: 2.839

2.  Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.

Authors:  Kathleen M Gura; Christopher P Duggan; Sharon B Collier; Russell W Jennings; Judah Folkman; Bruce R Bistrian; Mark Puder
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

3.  The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants.

Authors:  Patrick J Javid; Sharon Collier; Denise Richardson; Julie Iglesias; Kathleen Gura; Clifford Lo; Heung Bae Kim; Christopher P Duggan; Tom Jaksic
Journal:  J Pediatr Surg       Date:  2005-06       Impact factor: 2.545

4.  Differences in essential fatty acid requirements by enteral and parenteral routes of administration in patients with fat malabsorption.

Authors:  P B Jeppesen; C E Høy; P B Mortensen
Journal:  Am J Clin Nutr       Date:  1999-07       Impact factor: 7.045

Review 5.  Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease.

Authors:  Berthold Koletzko; Olivier Goulet
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-05       Impact factor: 4.294

6.  The relationship between the ventilation and lactate thresholds following normal, low and high carbohydrate diets.

Authors:  T M McLellan; G C Gass
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

7.  Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure.

Authors:  G De Marco; D Sordino; E Bruzzese; S Di Caro; D Mambretti; A Tramontano; C Colombo; P Simoni; A Guarino
Journal:  Aliment Pharmacol Ther       Date:  2006-07-15       Impact factor: 8.171

8.  Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome.

Authors:  Ivan R Diamond; Anca Sterescu; Paul B Pencharz; Jae H Kim; Paul W Wales
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

9.  High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis.

Authors:  Theresa C Willis; Beth A Carter; Stefanie P Rogers; Keli M Hawthorne; Penni D Hicks; Steven A Abrams
Journal:  JPEN J Parenter Enteral Nutr       Date:  2009-07-08       Impact factor: 4.016

10.  Essential fatty acid deficiency in patients receiving home parenteral nutrition.

Authors:  P B Jeppesen; C E Høy; P B Mortensen
Journal:  Am J Clin Nutr       Date:  1998-07       Impact factor: 7.045

View more
  6 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

2.  Strategies for early metabolic disturbances in patients with an end jejunostomy or end ileostomy. Experience from a specialized Home Parenteral Nutrition (HPN) center.

Authors:  Michał Ławiński; Dominika Haraszczuk; Aleksandra Gradowska; Justyna Z Kostro; Agnieszka Bzikowska; Jacek Sobocki
Journal:  Prz Gastroenterol       Date:  2016-03-16

Review 3.  Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children.

Authors:  Lorenzo Norsa; Emanuele Nicastro; Angelo Di Giorgio; Florence Lacaille; Lorenzo D'Antiga
Journal:  Nutrients       Date:  2018-05-24       Impact factor: 5.717

4.  Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit.

Authors:  Tamorah Lewis; Simisola Kuye; Ashley Sherman
Journal:  BMC Pediatr       Date:  2018-06-20       Impact factor: 2.125

Review 5.  Providing the Best Parenteral Nutrition before and after Surgery for NEC: Macro and Micronutrients Intakes.

Authors:  Silvia Guiducci; Miriam Duci; Laura Moschino; Marta Meneghelli; Francesco Fascetti Leon; Luca Bonadies; Maria Elena Cavicchiolo; Giovanna Verlato
Journal:  Nutrients       Date:  2022-02-22       Impact factor: 5.717

6.  Feeding Intolerance and Poor Growth in Infants with Gastroschisis: Longitudinal Experience with Consecutive Patients over Thirteen Years.

Authors:  Saloni Balgi; Sarita Singhal; Georgia Mueller; Beau Batton
Journal:  J Neonatal Surg       Date:  2015-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.